A $1bn Biosimilar? Amgen Enjoying Early Monopoly On Aflibercept Competition

Firm Eyeing $4bn Biosimilar Offering By 2030; US Soliris Biosimilar Launch Imminent

 
• By Dean Rudge
  
Economic recovery and growing wealth business metaphor as a group of trees shaped as a dollar sign growing leaves and bearing fruit as a symbol of wealth and financial success in a growth industry.

More from Earnings

More from Products